• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS ANGIOVAC / ANGIODYNAMICS; CATHETER, CANNULA & TUBING, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS ANGIOVAC / ANGIODYNAMICS; CATHETER, CANNULA & TUBING, VASCULAR Back to Search Results
Catalog Number H965251850
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Death (1802)
Event Date 12/14/2016
Event Type  Death  
Manufacturer Narrative
Although no sample will be returned to angiodynamics for evaluation, the investigation into this event is on-going.Upon completion of the investigation, a supplemental medwatch will be submitted.(b)(4).Device not returned to manufacturer.
 
Event Description
As reported by angiodynamics' clinical specialist: patient's indication for angiovac procedure was right atrial thrombus.Patient's co-morbidities were endocarditis, was septic, and hx of ivdu.Patient was stable at time of procedure, but with high venous pressures per md.Pulmonary embolism occurred during case.When the pe occurred is unknown, as there was no visualization of the embolization.The pe was diagnosed at the end of the case by md based on end tidal co2 and saturations decreasing.The angiovac was out of the patient at that time.The patient's condition at that time was "stable." follow-up with the physician regarding the patient's current status has indicated that the patient expired one week after the procedure due to her overall poor health.The md did not attribute the patient's death to the angiovac device.((b)(4)).
 
Manufacturer Narrative
A review of the device history records was performed for the indicated packaging and component lots for any deviations related to the reported defect of the complaint.The review confirms that the lots met all material, assembly and performance specifications.The angiodynamics complaint report was reviewed for the angiovac product family and the failure mode "patient injury/death." no adverse trend was identified.Although no used device was returned for evaluation, it is not believed that a device malfunction occurred: information from the physician received by angiodynamics' sales representative indicated that " the patient expired 1 week after the procedure due to her overall poor health status.The md did not attribute the patient's death to the device." directions for use provided with the angiovac cannula include the following: "warnings selection of the patient as a candidate for use with this device and for such procedures as it is intended is the physicians' sole responsibility.The outcome is dependent on many variables including, patient pathology, surgical procedure, and perfusion procedure/technique.The benefits of use of this device must be weighed against the risks including risks of systemic anticoagulation and must be assessed by the prescribing physician.As with all medical devices, this device and ancillary equipment are to be used by trained physicians only.Specifically, this device is to be used only by medical personnel experienced with initiating and monitoring extracorporeal bypass and by physicians trained and experienced using surgical and/or percutaneous (seldinger) vascular access techniques.Adverse events: this device, as do all extracorporeal blood vessel devices, has possible side effects, which include but are not limited to infections, blood loss, thrombus formation, embolic events, vessel, ventricular or valvular damage and complications of percutaneous or surgical insertion techniques.These may occur if the instructions for use are not followed.Possible complications include those normally associated with large bore surgical and/or percutaneous vessel catheterization/cannulation, anticoagulation, extracorporeal circulation and application of intravascular introducer systems which include but are not limited to: death, pulmonary embolism." ((b)(4)).Device not returned to manufacturer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANGIOVAC / ANGIODYNAMICS
Type of Device
CATHETER, CANNULA & TUBING, VASCULAR
Manufacturer (Section D)
ANGIODYNAMICS
10 glens falls technical park
glens falls NY 12801
Manufacturer (Section G)
ANGIODYNAMICS
10 glens falls technical park
glens falls NY 12801
Manufacturer Contact
law ryan
10 glens falls technical park
glens falls, NY 12801
5187424488
MDR Report Key6237033
MDR Text Key64342891
Report Number1317056-2017-00004
Device Sequence Number1
Product Code DWF
UDI-Device IdentifierH965251850
UDI-PublicH965251850
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142593
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/21/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date04/30/2018
Device Catalogue NumberH965251850
Device Lot Number5020900
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/14/2016
Initial Date FDA Received01/10/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received06/21/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/06/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age35 YR
-
-